Charney Laurence N 4

What Happened

• Laurence N. Charney, a director of TG Therapeutics, reported two gifts of common stock: 30,000 shares on 2026-01-28 and 13,197 shares on 2026-01-29. Both transactions are listed as gifts at $0.00 per share, meaning no cash was received by the reporting person. Total shares transferred: 43,197.

Key Details

• Transaction dates and prices: 2026-01-28 — 30,000 shares @ $0.00; 2026-01-29 — 13,197 shares @ $0.00.
• Reported proceeds: $0 (dispositions via gift).
• Filing date (Form 4): 2026-01-29; the filing was made the day after the first gift and appears to be timely under the SEC’s two-business-day rule.
• Footnote F1: These transfers are described as bona fide gifts to the reporting person’s children; Charney does not retain beneficial ownership or pecuniary interest after the transfers.
• Footnote F2: The filing notes that reported holdings may include restricted common stock that vests over various periods.

Context

• Gifts are disposals for reporting purposes and do not necessarily indicate the insider’s view on the company’s prospects; they often reflect personal or family estate planning. No purchase or sale for cash was reported in this filing.